Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.

@article{Shen2019IncidenceAE,
  title={Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.},
  author={T. Shen and Yingxia Liu and J. Shang and Q. Xie and J. Li and Ming Yan and Jianming Xu and J. Niu and Jiajun Liu and P. Watkins and G. Aithal and R. Andrade and X. Dou and L. Yao and Fang-Fang Lv and Q. Wang and Yongguo Li and X. Zhou and Y. Zhang and P. Zong and Bin Wan and Z. Zou and D. Yang and Y. Nie and Dongliang Li and Yuya Wang and Xian Han and H. Zhuang and Y. Mao and C. Chen},
  journal={Gastroenterology},
  year={2019},
  volume={156 8},
  pages={
          2230-2241.e11
        }
}
BACKGROUND & AIMS We performed a nationwide, retrospective study to determine the incidence and causes of drug-induced liver injury (DILI) in mainland China. METHODS We collected data on a total of 25,927 confirmed DILI cases, hospitalized from 2012 through 2014 at 308 medical centers in mainland China. We collected demographic, medical history, treatment, laboratory, disease severity, and mortality data from all patients. Investigators at each site were asked to complete causality… Expand
The Characteristics, Prevalence, and Risk Factors of Drug-Induced Liver Injury Among Brucellosis Inpatients in Xinjiang, China
TLDR
Obesity, regular alcohol intake, and decreased serum albumin were the independent risk factors of DILI in patients with brucellosis after adjusting for gender, age, and ethnicity. Expand
Characterization of patients diagnosed with drug-induced liver injury
Introduction and Objectives: Drug-induced liver injury (DILI) is the most common cause of acute liver failure in the USA, and a major cause of medication discontinuation. However, DILI is oftenExpand
The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
TLDR
Hy's law, presence of jaundice or MELD were predictors of mortality, and more than 50 different agents were associated with DILI, with India accounting for the majority of cases. Expand
RE: Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
no implicated drug, the patient was excluded. Yet in the list of drugs contributing to death the authors mention that a number of drug details were not available. These statements are contradictory.Expand
Etiology and Pattern of Drug Induced Liver Injury in a Tertiary Care Hospital of Nepal
TLDR
The most common pattern of liver injury seen was mixed pattern which was present in 63%, followed by cholestatic and hepatocellular pattern, which means that patients should be very careful while prescribing these frequently used drugs. Expand
Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China
TLDR
The results indicate that traditional Chinese medicine or herbal and dietary supplements were the prevalent causal agents of HILI, which was characterized by higher frequencies of hepatocellular injury. Expand
Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases
TLDR
China and Korea are top in presenting RUCAM-based HILI cases and other Asian countries are encouraged to follow, according to the aim of the current analysis. Expand
A simple method to identify undiagnosed drug-induced liver injury (DILI) and its application in oncology pharmacy practice
  • H. Wen, Maojun Ge, Di Yao, L. Liu
  • Medicine
  • Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
  • 2019
TLDR
A reliable and simple method to identify undiagnosed drug-induced liver injury was successfully established and an annual incidence of 0.69% of chemotherapy-associated liver injury in oncology department of the setting was found. Expand
Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison
  • Xiaohong Lei, Jianzhong Zhang, +10 authors Yimin Mao
  • Medicine
  • The Journal of international medical research
  • 2021
Objective In China, polyene phosphatidylcholine (PPC) is widely used to treat alanine aminotransferase (ALT) elevation associated with various liver diseases. Here, we assessed the efficacy andExpand
Research Progress of Pharmacogenomics in Drug-Induced Liver Injury
  • Qihui Shao, Xinyu Mao, Zhixuan Zhou, Cong Huai, Zhiling Li
  • Frontiers in Pharmacology
  • 2021
Background: Drug-induced liver injury (DILI) is a common and serious adverse drug reaction with insufficient clinical diagnostic strategies and treatment methods. The only clinically well-receivedExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 50 REFERENCES
Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
TLDR
In a population-based study in Iceland, the incidence of DILI was the highest reported to date and the highest risk of hepatotoxicity was associated with azathioprine and infliximab, but the actual number of cases attributed to these agents was small. Expand
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
TLDR
Mortality from DILI is significantly higher in individuals with pre-existing liver disease or concomitant severe skin reactions compared with patients without, and additional studies are needed to confirm the association between azithromycin and increased DILi in patients with chronic liver disease. Expand
A Prospective Nationwide Study of Drug-Induced Liver Injury in Korea
TLDR
DILI appears to be a highly relevant health problem in Korea and a more objective and reproducible causality assessment tool is strongly desired as the RUCAM scale frequently undercounts the cases caused by herbs owing to a lack of previous information and incompatible time criteria. Expand
Single-Center Experience With Drug-Induced Liver Injury From India: Causes, Outcome, Prognosis, and Predictors of Mortality
TLDR
DILI results in significant overall mortality (17.3%) and ATDs, anti-convulsants, sulphonamides, and olanzapine are the leading causes of DILI. Expand
Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21 789 patients
TLDR
DILI in China has a different etiology from that in Europe and USA, and NSAIDs, which are the most common causes of DILi in western populations, are uncommon in China. Expand
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
TLDR
This report summarizes the causes, clinical features, and outcomes from the first 300 patients enrolled in a prospective study to recruit patients with suspected idiosyncratic drug-induced liver injury and create a repository of biological samples for analysis. Expand
Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.
TLDR
Patients with drug-induced hepatocellular jaundice have 11.7% chance of progressing to death or transplantation, and amoxicillin-clavulanate stands out as the most common drug related to DILI. Expand
Outcome and prognostic markers in severe drug‐induced liver disease
TLDR
Age, aspartate aminotransferase (AST) and bilirubin were found to independently predict death or liver transplantation in the hepatocellular group, whereas among patients with cholestatic/mixed liver injury, bilirUBin was the only independent predictor. Expand
Incidence of drug‐induced hepatic injuries: A French population‐based study
TLDR
The results suggest that the number of hepatic ADRs in the French population would be 16 times greater than the number noted by spontaneous reporting to French regulatory authorities. Expand
Acute and clinically relevant drug-induced liver injury: a population based case-control study.
TLDR
Idiopathic, acute and clinically relevant liver injury, which has the use of drugs as the most probable aetiology, is a rare event in the general population and the relative risks of 40 drugs/therapeutic classes are provided. Expand
...
1
2
3
4
5
...